Nanexa AB (NANEXA) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.073x

Based on the latest financial reports, Nanexa AB (NANEXA) has a cash flow conversion efficiency ratio of -0.073x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.66 Million ≈ $-1.04 Million USD) by net assets (Skr132.87 Million ≈ $14.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NANEXA market cap for the company's overall valuation and market capitalisation.

Nanexa AB - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nanexa AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanexa AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanexa AB ranked by their cash flow conversion efficiency. Explore Nanexa AB cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Gold Resource Corporation NYSE MKT:GORO	-0.013x
Endava plc F:2Y5	0.050x
Ice Make Refrigeration Limited NSE:ICEMAKE	-0.437x
Eusu Holdings KO:000700	0.037x
Kulmbacher Brauerei Aktien-Gesellschaft MU:KUL	0.001x
Equillium Inc NASDAQ:EQ	-0.273x
Unifi Inc NYSE:UFI	0.035x
RiverNorth Managed Duration Municipal Income Fund II Inc. NYSE:RMMZ	N/A

Annual Cash Flow Conversion Efficiency for Nanexa AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nanexa AB from 2014 to 2025. View Nanexa AB stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr101.53 Million ≈ $10.93 Million	Skr-1.46 Million ≈ $-157.33K	-0.014x	+96.14%
2024-12-31	Skr70.92 Million ≈ $7.63 Million	Skr-26.43 Million ≈ $-2.84 Million	-0.373x	+16.29%
2023-12-31	Skr95.83 Million ≈ $10.31 Million	Skr-42.66 Million ≈ $-4.59 Million	-0.445x	-516.99%
2022-12-31	Skr109.10 Million ≈ $11.74 Million	Skr-7.87 Million ≈ $-847.05K	-0.072x	+56.56%
2021-12-31	Skr151.29 Million ≈ $16.28 Million	Skr-25.13 Million ≈ $-2.70 Million	-0.166x	+57.21%
2020-12-31	Skr43.35 Million ≈ $4.67 Million	Skr-16.83 Million ≈ $-1.81 Million	-0.388x	-2.54%
2019-12-31	Skr24.88 Million ≈ $2.68 Million	Skr-9.42 Million ≈ $-1.01 Million	-0.379x	+8.75%
2018-12-31	Skr16.29 Million ≈ $1.75 Million	Skr-6.76 Million ≈ $-727.11K	-0.415x	-124.54%
2017-12-31	Skr27.46 Million ≈ $2.95 Million	Skr-5.07 Million ≈ $-545.87K	-0.185x	+51.07%
2016-12-31	Skr16.96 Million ≈ $1.83 Million	Skr-6.41 Million ≈ $-689.32K	-0.378x	+30.46%
2015-12-31	Skr6.07 Million ≈ $652.70K	Skr-3.29 Million ≈ $-354.41K	-0.543x	-241.43%
2014-12-31	Skr1.47 Million ≈ $158.09K	Skr563.99K ≈ $60.69K	0.384x	--

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$116.93 Million

Skr1.09 Billion SEK

Market Cap Rank

#18691 Global

#324 in Sweden

Share Price

Skr5.88

Change (1 day)

+5.00%

52-Week Range

Skr1.61 - Skr6.33

All Time High

Skr15.20